Influence of AT₁ Receptor Blockade on Blood Pressure, Renal Haemodynamics and Hormonal Responses to Intravenous Angiotensin II Infusion in Hypertensive Patients

By Fridman Katarina U. B.   Elmfeldt Dag   Wysocki Marian   Friberg Peter R.   Andersson Ove K.  

Blood Pressure, Vol. 11, Iss. 4, 2002-07 ,pp. : 244-252

Informa Healthcare

Access to resources Recommend Favorite

Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism: Focus on Olmesartan Medoxomil

By Enrico Agabiti Rosei  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 231-243

Adis International

Access to resources Recommend Favorite

Treating Hypertension with Angiotensin II Receptor Blockers: A Step Ahead of Blood Pressure Reduction?

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Challenges for the Prevention of Primary and Secondary Stroke. The importance of lowering blood pressure and total cardiovascular risk

By Chalmers John   Chapman Neil  

Blood Pressure, Vol. 10, Iss. 5-6, 2001-11 ,pp. : 344-351

Informa Healthcare

Access to resources Recommend Favorite

Beyond blood pressure: pulse wave analysis – a better way of assessing cardiovascular risk?

By Davies Justine I   Struthers Allan D  

Future Cardiology, Vol. 1, Iss. 1, 2005-01 ,pp. : 69-78

Future Medicine

Access to resources Recommend Favorite